Nuzenio

Tg Therapeutics

Tg Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 16 publisher sources 100/100 entity strength

Latest news

TG Therapeutics (TGTX) Is Down 7.4% After Q2 Profit Drop Despite Higher 2026 Revenue Guidance – Has The Bull Case Changed? - SahmSahm · Sat, 08 Aug 2026 18:38:48 GMTDirector gifts 6,050 TG Therapeutics (TGTX) shares to 501(c)(3) - Stock TitanStock Titan · Fri, 07 Aug 2026 21:01:37 GMTJPMorgan Chase & Co. Issues Positive Forecast for TG Therapeutics (NASDAQ:TGTX) Stock Price - MarketBeatMarketBeat · Fri, 07 Aug 2026 17:02:18 GMTTG Therapeutics (TGTX) Looks Fairly Valued After Raised 2026 Guidance And Mixed Q2 Earnings - simplywall.stsimplywall.st · Thu, 06 Aug 2026 08:14:06 GMTCalifornia State Teachers Retirement System Increases Stock Position in TG Therapeutics, Inc. $TGTX - MarketBeatMarketBeat · Thu, 06 Aug 2026 07:45:20 GMTTG Therapeutics 2026: Revenue $240.34M, EPS $0.05— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:02:08 GMTTG Therapeutics (NASDAQ: TGTX) grows 2026 revenue to $445 million - Stock TitanStock Titan · Wed, 05 Aug 2026 21:01:51 GMTTG Therapeutics: BRIUMVI Revenue Jumps 64% To $227.7 Million - Pulse 2.0Pulse 2.0 · Wed, 05 Aug 2026 16:48:41 GMT

Timeline

Sat, 08 Aug 2026 18:38:48 GMTTG Therapeutics (TGTX) Is Down 7.4% After Q2 Profit Drop Despite Higher 2026 Revenue Guidance – Has The Bull Case Changed? - Sahm
Fri, 07 Aug 2026 21:01:37 GMTDirector gifts 6,050 TG Therapeutics (TGTX) shares to 501(c)(3) - Stock Titan
Fri, 07 Aug 2026 17:02:18 GMTJPMorgan Chase & Co. Issues Positive Forecast for TG Therapeutics (NASDAQ:TGTX) Stock Price - MarketBeat
Thu, 06 Aug 2026 08:14:06 GMTTG Therapeutics (TGTX) Looks Fairly Valued After Raised 2026 Guidance And Mixed Q2 Earnings - simplywall.st
Thu, 06 Aug 2026 07:45:20 GMTCalifornia State Teachers Retirement System Increases Stock Position in TG Therapeutics, Inc. $TGTX - MarketBeat
Wed, 05 Aug 2026 21:02:08 GMTTG Therapeutics 2026: Revenue $240.34M, EPS $0.05— 10-Q Summary - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tg Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

16 distinct publisher/source names are currently connected to this entity page.